A Novel MVA Vectored Chikungunya Virus Vaccine Elicits Protective Immunity in Mice

@inproceedings{WegerLucarelli2014ANM,
  title={A Novel MVA Vectored Chikungunya Virus Vaccine Elicits Protective Immunity in Mice},
  author={James Weger-Lucarelli and Haiyan Chu and Matthew T Aliota and Charalambos D. Partidos and Jorge E Osorio},
  booktitle={PLoS neglected tropical diseases},
  year={2014}
}
BACKGROUND Chikungunya virus (CHIKV) is a re-emerging arbovirus associated with febrile illness often accompanied by rash and arthralgia that may persist for several years. Outbreaks are associated with high morbidity and create a public health challenge for countries affected. Recent outbreaks have occurred in both Europe and the Americas, suggesting CHIKV may continue to spread. Despite the sustained threat of the virus, there is no approved vaccine or antiviral therapy against CHIKV… CONTINUE READING
Highlighted Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 12 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 92 REFERENCES

in mice with compromised interferon ( IFN ) signaling

  • CJ Roy, AP Adams, E Wang, K Plante, R Gorchakov
  • 2014